BioPharm International
June 01, 2013
Features
26
6
A Q&A with SCHOTT Pharmaceutical Systems and West Pharmaceutical Services
June 01, 2013
Regulatory Beat
26
6
Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
June 01, 2013
Outsourcing Insights
26
6
Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
June 01, 2013
European Beat
26
6
A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.
June 01, 2013
Features
26
6
An integrated focus on product design, development, operation, and control.
June 01, 2013
Global Report
26
6
The Taiwanese government engages in regulatory science in a move to boost its pharmaceutical sector.
June 01, 2013
Features
26
6
Quality control for disposable-bags
June 01, 2013
From the Editor
26
6
Ranbaxy's $500 million settlement for producing adulterated drugs and fradulent data provides a cautionary tale for patients, FDA, and drug manufacturers.
June 01, 2013
Manufacturing Best Practices
26
6
Maintaining flexibility in biopharmaceutical manufacturing can deliver positive results.
June 01, 2013
Emerging Markets
26
6
A unique demographic and payer mix make ASEAN an increasingly attractive region.
June 01, 2013
Inside Standards
26
6
Companies can use metrics as a tool to help drive positive change and quality process improvements.
June 01, 2013
Boot Camp Business Guide
26
6
The authors provide common misconceptions and key concepts behind reliability engineering.
June 01, 2013
Issue PDF
26
6
Click the title above to open the BioPharm International June 2013 issue in an interactive PDF format.